CD40 and amyotrophic lateral sclerosis: CD40 signaling between antigen presenting cells (APCs) and T-cells is upregulated in the blood of 56% of patients with amyotrophic lateral sclerosis (ALS); a discovery that inspired the development of a monoclonal antibody to CD40L, which delayed the onset of paralysis and extended survival in murine models [48].